These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7618007)

  • 21. Salmeterol xinafoate vs albuterol in asthma: was race a factor?
    Olopade CO
    JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862
    [No Abstract]   [Full Text] [Related]  

  • 22. Bronchodilator treatment in asthma. Study too small to detect increase in deaths.
    Bunney R
    BMJ; 1993 Jun; 306(6892):1610; author reply 1611. PubMed ID: 8101118
    [No Abstract]   [Full Text] [Related]  

  • 23. Are beta-adrenergic bronchodilators safe?
    Eggleston PA
    Pediatrics; 1997 May; 99(5):729-30. PubMed ID: 9113951
    [No Abstract]   [Full Text] [Related]  

  • 24. Misleading data analyses in salmeterol (SMART) study.
    Lurie P; Wolfe SM
    Lancet; 2005 Oct; 366(9493):1261-2; discussion 1262. PubMed ID: 16214589
    [No Abstract]   [Full Text] [Related]  

  • 25. Prior use of long-acting beta-agonists: friend or foe in the emergency department?
    Peters SP; Fish JE
    Am J Med; 1999 Sep; 107(3):283-5. PubMed ID: 10492323
    [No Abstract]   [Full Text] [Related]  

  • 26. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
    Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of salmeterol in patients with allergic bronchial asthma].
    Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
    Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol and paroxetine: more evidence for paradoxical medicine.
    Yun AJ; Lee PY; Doux JD
    Med Hypotheses; 2006; 66(5):1037-8. PubMed ID: 16364562
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-acting beta-2-agonists in the treatment of asthma].
    Rochat T
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long acting beta-2 agonists. Discussion of their use in asthma].
    Aumiller J
    MMW Fortschr Med; 2009 Apr; 151(15):14. PubMed ID: 19728671
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-acting beta2-agonist bronchodilators safety for asthma treatment].
    Giubergia V
    Arch Argent Pediatr; 2009 Aug; 107(4):291-3. PubMed ID: 19753432
    [No Abstract]   [Full Text] [Related]  

  • 35. Salmeterol vs. formoterol: a comparison of rapid bronchodilator effect in a randomized controlled trial.
    Singhania N; Dhamija R; Lodha R; Kabra SK
    Indian Pediatr; 2008 Mar; 45(3):225-8. PubMed ID: 18367770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting beta agonists--prescribe with care.
    Crane J
    N Z Med J; 2006 Jul; 119(1237):U2064. PubMed ID: 16862206
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
    Cash R; Blonski J
    J Fam Pract; 2001 Sep; 50(9):802. PubMed ID: 11674917
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting beta 2-agonists: the new symptom controllers for asthma.
    Jenkins CR
    Med J Aust; 1999 Sep; 171(5):255-8. PubMed ID: 10495758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.